Abstract
We are able to subdivide highly sensitised renal patients who wish to enter our immunoadsorption programme into two groups; those who will require acute pretransplant immunoadsorption only and those requiring regular immunoadsorption prior to transplantation. This division of patients is based on the results obtained from laboratory assessment using protein A minicolumns. Patient’s plasma is passed down a minicolumn for 6 × 10 min cycles, a sample of plasma is kept after each cycle for analysis by cell flow cytometric cross-match (FCXM). The samples are screened against cells from two normal volunteers, one expressing a previously mismatched Class I HLA antigen (MMA) to which the patient has raised persistent IgG antibodies, the other, whilst not expressing any MMAs, should express a cross-reactive HLA Class I antigen (XRA) to which the patient has formed persistent IgG antibodies. Patients are allocated into the acute pretransplant immunoadsorption group if, after 6 minicolumn cycles, the T cell FCXM vs XRA and MMA is reduced to less than 1 Log median fluorescence intensity shift above the negative control and that both these values have been reduced by at least 15% from the preimmunoadsorption figure. If these criteria are not met, regular immunoadsorption is required under cover of cyclophosphamide. Eleven patients who have been allocated by these criteria have subsequently been transplanted without any incidence of hyperacute rejection.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Brocard JF, Farahmand H, Fassi S, Plaisant B, Fries E, Cantarovich M, Bismuth A, Lambert T, Hiesse C, Lantz O, Fries D, Charpentier B (1989) Attempt at depletion of anti-HLA antibodies in sensitized patients awaiting transplantation using extracorporeal immunoadsorption, polyclonal IgG, and immunosuppressive drugs. Transplant Proc 21: 733–734
Charpentier BM, Hiesse C, Kriaa F, Rousseau P, Farahmand H, Bismuth A, Fries D (1992) How to deal with the hyperimmunized potential recipients. Kidney Int (suppl) 38: S176 - S181
Esnault V, Bignon JD, Testa A, Preud’homme JL, Vergracht A, Soulillou JP (1990) Effect of protein A immunoadsorption on panel lymphocyte reactivity in hyperimmunized patients awaiting a kidney graft. Transplantation 50: 449–453
Gil-Vernet S, Grifió JM, Martorell J, Castelao AM, Serón D, Díaz C, Andrés E, Gonzalez-Castellanos L, Alsina J (1990) Anti-HLA antibody removal by immunoadsorption. Transplant Proc 22: 1904–1905
Palmer A, Taube D, Welsh K, Brynger H Delin K, Gjörstrup P, Konar J, Söderström T (1987) Extracorporeal immunoadsorption of anti-HLA antibodies: Preliminary clinical experience. Transplant Proc 19: 3750–3751
Palmer A, Welsh K, Gjorstrup P, Taube D, Bewick M, Thick M (1989) Removal of anti-HLA antibodies by extracorporeal immunoadsorption to enable renal transplantation. Lancet 1: 10
United Kingdom Transplant Support Service Authority (1995) Renal transplant audit 1984–1993
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1996 Springer-Verlag Berlin Heidelberg
About this paper
Cite this paper
Bevan, D.J. et al. (1996). Anticipation of highly sensitised renal patients’ immunoadsorption requirements by prescreening using protein A minicolumns. In: Mühlbacher, F., et al. Transplant International . Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-662-00818-8_6
Download citation
DOI: https://doi.org/10.1007/978-3-662-00818-8_6
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-540-61024-3
Online ISBN: 978-3-662-00818-8
eBook Packages: Springer Book Archive